Cajal Therapeutics
Developer of disease-altering therapies intended for the treatment of neurodegenerative diseases. The company creates viral tools and platforms to screen for the targets with functional impact on neur...
Valuation
$139M
Latest known
Share Price
N/A
Total Raised
$135.7M
Last Round
N/A